Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Hair loss in young men in Central India is linked to severe heart disease.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Hair loss in young adults is linked to harder arteries.

Using your own platelet-rich plasma (PRP) can effectively treat hair loss, increasing hair density and width with no side effects.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Eating a lot of soy might lower the chance of early hair loss in men likely to get it.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Finasteride helps treat hair loss by blocking enzyme activity.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Skin symptoms can indicate endocrine disorders and have various treatments.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.